AMERICAN INTERNATIONAL GROUP, INC. - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,227,199
+7.8%
17,559
+10.9%
0.01%
+14.3%
Q2 2023$1,137,903
+19.3%
15,835
+2.4%
0.01%
+16.7%
Q1 2023$954,005
-18.4%
15,467
+2.0%
0.01%
-25.0%
Q4 2022$1,169,291
+85.6%
15,160
+7.4%
0.01%
+60.0%
Q3 2022$630,000
+22.3%
14,120
+5.1%
0.01%
+66.7%
Q2 2022$515,000
-9.8%
13,441
-2.6%
0.00%0.0%
Q1 2022$571,000
+2.3%
13,795
-6.6%
0.00%0.0%
Q4 2021$558,000
+11.4%
14,766
-2.9%
0.00%0.0%
Q3 2021$501,000
-52.3%
15,207
-2.3%
0.00%
-25.0%
Q2 2021$1,050,000
+14.9%
15,569
-3.6%
0.00%
+33.3%
Q1 2021$914,000
-30.3%
16,148
+0.3%
0.00%
-40.0%
Q4 2020$1,312,000
+11.2%
16,105
-2.8%
0.01%
-16.7%
Q3 2020$1,180,000
-15.4%
16,567
-2.2%
0.01%
-14.3%
Q2 2020$1,394,000
+48.3%
16,945
+6.0%
0.01%
+40.0%
Q1 2020$940,000
-42.3%
15,985
+1.4%
0.01%
-16.7%
Q4 2019$1,629,000
+405.9%
15,758
-0.8%
0.01%
+500.0%
Q3 2019$322,000
-19.3%
15,890
+2.6%
0.00%
-50.0%
Q2 2019$399,000
+1377.8%
15,484
+126.4%
0.00%
Q1 2017$27,000
-37.2%
6,840
+7.0%
0.00%
Q4 2016$43,000
-99.9%
6,392
-0.3%
0.00%
Q3 2016$50,503,000
+4.7%
6,409
+0.1%
0.00%
Q2 2016$48,256,0006,4000.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,008,508$82,980,00048.53%
Fairmount Funds Management LLC 216,098$17,781,0007.93%
WMS Partners, LLC 250,000$20,570,0004.26%
RTW INVESTMENTS, LP 1,658,316$136,446,0003.84%
MORGAN JESS S & CO INC 39,328$3,236,0003.51%
RA Capital Management 2,035,132$167,451,0003.26%
Ghost Tree Capital, LLC 100,000$8,228,0002.17%
ACUTA CAPITAL PARTNERS, LLC 90,000$7,405,0002.14%
Avidity Partners Management LP 404,900$33,315,0002.14%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,085,836$89,343,0001.97%
View complete list of AXSOME THERAPEUTICS INC shareholders